Financhill
Sell
22

FTHM Quote, Financials, Valuation and Earnings

Last price:
$1.56
Seasonality move :
-8.67%
Day range:
$1.53 - $1.69
52-week range:
$1.32 - $4.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.09x
P/B ratio:
0.74x
Volume:
94.7K
Avg. volume:
76.1K
1-year change:
-57.65%
Market cap:
$35.1M
Revenue:
$345.2M
EPS (TTM):
-$1.28
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $111.2M $176.8M $330.2M $413M $345.2M
Revenue Growth (YoY) 43.85% 58.97% 86.8% 25.05% -16.4%
 
Cost of Revenues $105.3M $166.3M $300.5M $372.2M $308.1M
Gross Profit $5.9M $10.4M $29.7M $40.7M $37.1M
Gross Profit Margin 5.35% 5.91% 9% 9.86% 10.76%
 
R&D Expenses -- $372K $3.9M $7.7M $7.6M
Selling, General & Admin $9.9M $11.3M $34.6M $48.4M $42.1M
Other Inc / (Exp) -- $10K $374K -$914K -$335K
Operating Expenses $9.9M $11.7M $45.8M $67.5M $60.4M
Operating Income -$4M -$1.3M -$16.1M -$26.8M -$23.3M
 
Net Interest Expenses $109.7K $84K $7K -- $245K
EBT. Incl. Unusual Items -$4.1M -$1.3M -$15.7M -$27.7M -$23.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$8K -$8K -$3.2M -$54K $148K
Net Income to Company -$4.1M -$1.3M -$12.5M -$27.6M -$24M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.1M -$1.3M -$12.5M -$27.6M -$24M
 
Basic EPS (Cont. Ops) -$0.41 -$0.12 -$0.88 -$1.73 -$1.47
Diluted EPS (Cont. Ops) -$0.41 -$0.12 -$0.88 -$1.73 -$1.47
Weighted Average Basic Share $10M $11.4M $14.3M $16M $16.3M
Weighted Average Diluted Share $10M $11.4M $14.3M $16M $16.3M
 
EBITDA -$3.9M -$1.1M -$13.4M -$21.4M -$17.3M
EBIT -$4M -$1.3M -$16.1M -$26.8M -$23.3M
 
Revenue (Reported) $111.2M $176.8M $330.2M $413M $345.2M
Operating Income (Reported) -$4M -$1.3M -$16.1M -$26.8M -$23.3M
Operating Income (Adjusted) -$4M -$1.3M -$16.1M -$26.8M -$23.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $55.8M $100.9M $111.3M $93.5M $83.7M
Revenue Growth (YoY) 74.04% 80.74% 10.23% -15.94% -10.47%
 
Cost of Revenues $52.9M $91.3M $99.4M $83.8M $74.2M
Gross Profit $3M $9.7M $11.8M $9.8M $9.5M
Gross Profit Margin 5.33% 9.59% 10.62% 10.43% 11.4%
 
R&D Expenses -- $571K $1.5M $1.8M $2M
Selling, General & Admin $3.1M $10.2M $13M $10.6M $9.4M
Other Inc / (Exp) -- $104K -$126K -$18K -$3.3M
Operating Expenses $3.1M $13.4M $17.7M $15.1M $14.2M
Operating Income -$136K -$3.7M -$5.9M -$5.4M -$4.7M
 
Net Interest Expenses $16K $2K -- $88K $104K
EBT. Incl. Unusual Items -$152K -$3.6M -$6M -$5.5M -$8.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $32K -$210K -- $18K $17K
Net Income to Company -$184K -$3.4M -$6M -$5.5M -$8.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$184K -$3.4M -$6M -$5.5M -$8.1M
 
Basic EPS (Cont. Ops) -$0.02 -$0.24 -$0.38 -$0.34 -$0.40
Diluted EPS (Cont. Ops) -$0.02 -$0.24 -$0.38 -$0.34 -$0.40
Weighted Average Basic Share $12.2M $14.3M $15.8M $16.1M $20.4M
Weighted Average Diluted Share $12.2M $14.3M $15.8M $16.1M $20.4M
 
EBITDA -$91.8K -$2.8M -$4.5M -$3.8M -$6.7M
EBIT -$136K -$3.7M -$5.9M -$5.4M -$8M
 
Revenue (Reported) $55.8M $100.9M $111.3M $93.5M $83.7M
Operating Income (Reported) -$136K -$3.7M -$5.9M -$5.4M -$4.7M
Operating Income (Adjusted) -$136K -$3.7M -$5.9M -$5.4M -$8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $156.6M $288.2M $425M $354.6M $317.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $148.1M $264.8M $381.4M $318.8M $279.7M
Gross Profit $8.5M $23.4M $43.6M $35.7M $37.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $6M $9M $8.8M
Selling, General & Admin $9.7M $29.5M $47.8M $41.3M $39.4M
Other Inc / (Exp) $10K $193K -$509K -$295K -$1.2M
Operating Expenses $9.8M $36.5M $64.7M $61M $59.9M
Operating Income -$1.3M -$13.2M -$21M -$25.2M -$22M
 
Net Interest Expenses $109.4K $6K -- $136K $412K
EBT. Incl. Unusual Items -$1.4M -$13M -$21.5M -$25.7M -$23.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $34K -$2.9M -$242K -$184K $121K
Net Income to Company -$1.4M -$10.1M -$21.3M -$25.5M -$23.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.4M -$10.1M -$21.3M -$25.5M -$23.8M
 
Basic EPS (Cont. Ops) -$0.14 -$0.73 -$1.34 -$1.60 -$1.28
Diluted EPS (Cont. Ops) -$0.14 -$0.73 -$1.34 -$1.60 -$1.28
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$1.1M -$11.3M -$16.3M -$19.2M -$17.2M
EBIT -$1.3M -$13.1M -$21M -$25.3M -$22.8M
 
Revenue (Reported) $156.6M $288.2M $425M $354.6M $317.5M
Operating Income (Reported) -$1.3M -$13.2M -$21M -$25.2M -$22M
Operating Income (Adjusted) -$1.3M -$13.1M -$21M -$25.3M -$22.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $123.4M $234.8M $329.5M $271.2M $243.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $116M $214.4M $295.2M $241.8M $213.4M
Gross Profit $7.4M $20.4M $34.3M $29.3M $30M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $1.9M $4M $5.2M $5.9M
Selling, General & Admin $7.2M $25.5M $38.7M $31.5M $29.3M
Other Inc / (Exp) $10K $193K -$690K -$181K -$1.1M
Operating Expenses $7.3M $32.3M $51.1M $44.5M $44M
Operating Income $39.5K -$11.9M -$16.8M -$15.2M -$13.9M
 
Net Interest Expenses $81.5K $4K $7K $167K $318K
EBT. Incl. Unusual Items -$32K -$11.7M -$17.5M -$15.5M -$15.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $34K -$2.8M $185K $55K $28K
Net Income to Company -$66K -$8.9M -$17.7M -$15.5M -$15.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$66K -$8.9M -$17.7M -$15.5M -$15.3M
 
Basic EPS (Cont. Ops) -$0.00 -$0.64 -$1.10 -$0.97 -$0.78
Diluted EPS (Cont. Ops) -$0.00 -$0.64 -$1.10 -$0.97 -$0.78
Weighted Average Basic Share $32.1M $41.8M $48.2M $48.1M $59.4M
Weighted Average Diluted Share $32.2M $41.8M $48.2M $48.1M $59.4M
 
EBITDA $157.5K -$10M -$13M -$10.7M -$10.8M
EBIT $49.5K -$11.8M -$16.8M -$15.2M -$14.8M
 
Revenue (Reported) $123.4M $234.8M $329.5M $271.2M $243.4M
Operating Income (Reported) $39.5K -$11.9M -$16.8M -$15.2M -$13.9M
Operating Income (Adjusted) $49.5K -$11.8M -$16.8M -$15.2M -$14.8M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $579.4K $28.6M $37.8M $8.3M $7.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $660.9K $1.6M $4M $3.1M $3.4M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $413.8K $1.7M $2.6M $3.7M $3.7M
Total Current Assets $1.7M $32.9M $54.5M $18.8M $23.2M
 
Property Plant And Equipment $371.1K $592K $5.6M $8.5M $6.5M
Long-Term Investments -- -- -- -- --
Goodwill -- $799K $20.5M $25.6M $25.6M
Other Intangibles $464.8K $922K $24.2M $27.3M $23.9M
Other Long-Term Assets -- $56K $93K $52K $58K
Total Assets $2.5M $35.2M $104.9M $80.2M $79.3M
 
Accounts Payable $946K $2.6M $5.3M $3.3M $3.4M
Accrued Expenses $1M $570K $1.4M $562K $719K
Current Portion Of Long-Term Debt $17.1K $256K $831K $564K $416K
Current Portion Of Capital Lease Obligations $89.6K $140K $870K $1.6M $1.5M
Other Current Liabilities $139.9K $933K $90K -- --
Total Current Liabilities $2.9M $5M $21.1M $12.5M $16.4M
 
Long-Term Debt $535.1K $283K $146K $129K $3.5M
Capital Leases -- -- -- -- --
Total Liabilities $3.6M $5.6M $24.8M $18.2M $24M
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -$1.2M $29.7M $80.2M $62M $55.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$1.2M $29.7M $80.2M $62M $55.2M
 
Total Liabilities and Equity $2.5M $35.2M $104.9M $80.2M $79.3M
Cash and Short Terms $579.4K $28.6M $37.8M $8.3M $7.4M
Total Debt $622.6K $539K $10.6M $4.3M $12.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $31M $8.8M $14.5M $6.6M $13.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.1M $3.6M $4.2M $4.1M $3.2M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1M $2.1M $4.8M $3.6M $5.3M
Total Current Assets $34.2M $28.8M $32.8M $21.6M $35M
 
Property Plant And Equipment $356.6K $5.5M $8.7M $6.9M $6M
Long-Term Investments -- -- -- -- --
Goodwill -- $20.3M $25.5M $25.6M $19.3M
Other Intangibles $721.8K $24M $27.9M $24.6M $17.5M
Other Long-Term Assets -- $95K $52K $59K $81K
Total Assets $35.2M $78.7M $95M $78.8M $80.9M
 
Accounts Payable $2.1M $4M $4.9M $3.4M $4.9M
Accrued Expenses $1M $1.8M $1.5M $501K $1.4M
Current Portion Of Long-Term Debt $204.3K $1.2M $514K $290K $3.7M
Current Portion Of Capital Lease Obligations $78.5K $1.7M $1.5M $1.5M $1.3M
Other Current Liabilities -- $3.5M -- -- --
Total Current Liabilities $4.5M $25.8M $20.7M $15.1M $22.6M
 
Long-Term Debt $288.7K $146K $270K $3.5M $5.1M
Capital Leases -- -- -- -- --
Total Liabilities $5M $29.1M $26.4M $23M $33.8M
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $30.3M $49.6M $68.6M $55.8M $47.1M
 
Total Liabilities and Equity $35.2M $78.7M $95M $78.8M $80.9M
Cash and Short Terms $31M $8.8M $14.5M $6.6M $13.1M
Total Debt $493K $11.7M $9.3M $10.6M $17.4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$4.1M -$1.3M -$12.5M -$27.6M -$24M
Depreciation & Amoritzation $60.4K $165K $2.7M $5.3M $5.9M
Stock-Based Compensation $1.6M $728K $4M $9.1M $13M
Change in Accounts Receivable $944.4K -$1.3M -$180.6M -$245.8M -$154.8M
Change in Inventories -- -- -- -- --
Cash From Operations -$1.1M -$1.2M -$11.7M -$6.6M -$10.6M
 
Capital Expenditures $372.8K $488K $3.5M $4.1M $1.8M
Cash Acquisitions -- -$257K -$11.1M -$1.6M -$35K
Cash From Investing -$372.8K -$910K -$14.6M -$7.1M -$1.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $454K $1.1M $211.4M $154.3M
Long-Term Debt Repaid -$16.8K -$517K -$740K -$221.2M -$146.2M
Repurchase of Common Stock -- -$30K -- -$6M --
Other Financing Activities -- -$3.2M -$2.5M -- -$1.4M
Cash From Financing $1.1M $31.1M $34.6M -$15.9M $11.6M
 
Beginning Cash (CF) $1M $579K $29.6M $37.9M $8.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$429.1K $29M $8.4M -$29.5M -$840K
Ending Cash (CF) $579.4K $29.6M $37.9M $8.4M $7.5M
 
Levered Free Cash Flow -$1.5M -$1.7M -$15.2M -$10.6M -$12.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$184K -$3.4M -$6M -$5.5M -$8.1M
Depreciation & Amoritzation $44.2K $931K $1.4M $1.6M $1.3M
Stock-Based Compensation $96.8K $769K $2.1M $3.3M $2M
Change in Accounts Receivable -$688.8K -$65.7M -$73.2M -$26.1M -$60.1M
Change in Inventories -- -- -- -- --
Cash From Operations -$979.6K -$3.9M -$6.8M -$1.5M -$330K
 
Capital Expenditures $130.2K $1.6M $763K $449K $1M
Cash Acquisitions -- $45K -- -- --
Cash From Investing -$130.2K -$1.6M -$763K -$449K -$1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $420 $1.8M $178.1M $38.9M $69.4M
Long-Term Debt Repaid -$504.5K -$392K -$182.4M -$39.2M -$65.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$3.2M -- -- -$282K $245K
Cash From Financing $30.6M $1.4M $2.7M -$491K $4M
 
Beginning Cash (CF) $1.5M $16.4M $19.6M $9.2M $10.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $29.5M -$4M -$4.9M -$2.4M $2.6M
Ending Cash (CF) $31M $12.3M $14.7M $6.8M $13.4M
 
Levered Free Cash Flow -$1.1M -$5.5M -$7.6M -$1.9M -$1.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.4M -$10.1M -$21.3M -$25.5M -$23.8M
Depreciation & Amoritzation $126.9K $1.8M $4.8M $6M $5.5M
Stock-Based Compensation $372.5K $3.2M $7.6M $12M $10.8M
Change in Accounts Receivable -$1.7M -$109.1M -$276.9M -$152.8M -$234.2M
Change in Inventories -- -- -- -- --
Cash From Operations -$1.2M -$7.5M -$11.6M -$6.3M -$8.7M
 
Capital Expenditures $487.3K $2.7M $4.3M $2M $2.7M
Cash Acquisitions -- -$11.2M -$2.6M $840K $7.4M
Cash From Investing -$487.3K -$14.1M -$6.9M -$2.5M $4.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $145.4M $239.4M
Long-Term Debt Repaid -$517.2K -$403K -$183.3M -$143.9M -$232.7M
Repurchase of Common Stock -- -- -$6M -- --
Other Financing Activities -- -- -- -- -$836K
Cash From Financing $31.6M $2.9M $20.9M $920K $10.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $29.9M -$18.7M $2.4M -$7.9M $6.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.7M -$10.2M -$15.9M -$8.3M -$11.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$66K -$8.9M -$17.7M -$15.5M -$15.3M
Depreciation & Amoritzation $108K $1.8M $3.8M $4.5M $4.1M
Stock-Based Compensation $322K $2.8M $6.5M $9.3M $7.1M
Change in Accounts Receivable -$1.6M -$109.5M -$205.8M -$112.8M -$192.2M
Change in Inventories -- -- -- -- --
Cash From Operations -$330K -$6.6M -$6.5M -$6.2M -$4.4M
 
Capital Expenditures $367K $2.6M $3.5M $1.4M $2.2M
Cash Acquisitions -- -$11M -$2.5M -- $7.4M
Cash From Investing -$367K -$13.6M -$5.9M -$1.4M $5.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $454K $3.2M $178.1M $112.2M $197.3M
Long-Term Debt Repaid -$513K -$399K -$182.9M -$105.7M -$192.1M
Repurchase of Common Stock -$30K -- -$6M -- --
Other Financing Activities -$3.2M -- -- -$566K -$8K
Cash From Financing $31.1M $2.9M -$10.8M $5.9M $5.2M
 
Beginning Cash (CF) $2.9M $71.8M $88.1M $24.4M $24.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $30.4M -$17.2M -$23.2M -$1.6M $5.9M
Ending Cash (CF) $33.3M $54.6M $64.9M $22.7M $30.2M
 
Levered Free Cash Flow -$697K -$9.2M -$9.9M -$7.6M -$6.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock